Jump to content

Flucetorex

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Boghog (talk | contribs) at 11:31, 26 November 2020 (consistent citation formatting). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Flucetorex
Identifiers
  • 2-(4-acetamidophenoxy)-N-[1-[3-(trifluoromethyl)phenyl]propan-2-yl]acetamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC20H21F3N2O3
Molar mass394.394 g·mol−1
3D model (JSmol)
  • CC(CC1=CC(=CC=C1)C(F)(F)F)NC(=O)COC2=CC=C(C=C2)NC(=O)C
  • InChI=1S/C20H21F3N2O3/c1-13(10-15-4-3-5-16(11-15)20(21,22)23)24-19(27)12-28-18-8-6-17(7-9-18)25-14(2)26/h3-9,11,13H,10,12H2,1-2H3,(H,24,27)(H,25,26)
  • Key:SKWBJBJQEUEFCY-UHFFFAOYSA-N

Flucetorex (INN) is an amphetamine, which was investigated as an anorectic, but does not appear to have ever been marketed.[1][2] It is related to fenfluramine.[3][4]

See also

References

  1. ^ Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 568–. ISBN 978-0-412-46630-4.
  2. ^ World Health Organization (2000). International Nonproprietary Names (INN) for Pharmaceutical Substances. World Health Organization. ISBN 978-0-11-986227-0.
  3. ^ Bray GA (1 July 1980). Obesity: comparative methods of weight control. Technomic. ISBN 978-0-87762-261-1.
  4. ^ Sullivan AC (1976). "Chapter 21: Agents for the Treatment of Obesity". Annual Reports in Medicinal Chemistry Volume 11. Annual Reports in Medicinal Chemistry. Vol. 11. pp. 200–208. doi:10.1016/S0065-7743(08)61404-9. ISBN 9780120405114. ISSN 0065-7743.